- Datum04.03.2026
- Uhrzeit13:00 - 14:00 Uhr
- Veranstalter
stock3
Novocure Ltd. Chart inkl. Chartanalyse
Charts analysieren
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen
Chart analysieren
Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate BSX | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-1,55 %
Intraday
13,29 %
1 Woche
12,33 %
1 Monat
2,86 %
Seit Jahresbeginn
-27,76 %
1 Jahr
-82,98 %
3 Jahre
-90,87 %
5 Jahre
-17,03 %
10 Jahre
Passender Service zu Novocure Ltd.
Webinar zu Novocure Ltd.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)9,820-21,550
- Jahrestief / Hoch ($)---
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Novocure Ltd.
Keine Dividenden verfügbar
Termine von Novocure Ltd.
- Apr23Novocure Ltd.Q1 2026 Earnings Release
- Jul23Novocure Ltd.Q2 2026 Earnings Release
- Okt22Novocure Ltd.Q3 2026 Earnings Release
Beschreibung
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
